STAGE II BREAST CANCER AJCC V6 AND V7
Clinical trials for STAGE II BREAST CANCER AJCC V6 AND V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE II BREAST CANCER AJCC V6 AND V7 trials appear
Sign up with your email to follow new studies for STAGE II BREAST CANCER AJCC V6 AND V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Shorter radiation for breast cancer: fewer side effects?
Disease control TerminatedThis study tests a new way to give radiation to women with early-stage breast cancer. Instead of treating the whole breast, it targets only the area where the cancer started and uses higher doses over fewer sessions. The goal is to see if this approach causes fewer side effects w…
Matched conditions: STAGE II BREAST CANCER AJCC V6 AND V7
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 11:50 UTC
-
Could an immune booster make chemo more effective for aggressive breast cancer?
Disease control OngoingThis study tests whether adding the immunotherapy drug atezolizumab to standard chemotherapy before surgery helps shrink tumors more effectively in people with stage II-III triple negative breast cancer. About 67 participants will receive either chemo alone or chemo plus atezoliz…
Matched conditions: STAGE II BREAST CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 11:48 UTC
-
Could a gel help fight breast cancer? new trial tests endoxifen
Disease control OngoingThis early-phase trial is testing a gel form of the drug endoxifen on the breast skin of 32 women scheduled for mastectomy. The goal is to find the safest dose and see how much drug gets into breast tissue. The study compares the gel to a placebo to understand side effects and po…
Matched conditions: STAGE II BREAST CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Immunotherapy after chemo shows promise for aggressive breast cancer
Disease control OngoingThis phase 3 trial tests whether adding the immunotherapy drug pembrolizumab after standard chemotherapy helps prevent triple-negative breast cancer from returning. About 1,155 patients with residual cancer after chemo are randomly assigned to receive pembrolizumab or a placebo. …
Matched conditions: STAGE II BREAST CANCER AJCC V6 AND V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Could 3 weeks of radiation be as good as 5 for breast cancer?
Symptom relief OngoingThis study compares a 3-week radiation schedule to the usual 5-week schedule for breast cancer patients who need radiation to the lymph nodes near the breast. The goal is to see if the shorter treatment is just as effective at preventing cancer from coming back, while also reduci…
Matched conditions: STAGE II BREAST CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 11:45 UTC
-
Proton beam radiation: a gentler option for breast cancer?
Symptom relief OngoingThis study looks at how well proton beam radiation works for early-stage breast cancer (stages 0 to II) and what side effects it causes. Researchers want to see if this precise type of radiation can kill cancer cells while causing less damage to healthy tissue and improving how t…
Matched conditions: STAGE II BREAST CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 11:32 UTC
-
Lifestyle makeover may boost breast cancer radiation outcomes
Symptom relief OngoingThis study tests whether an integrative oncology program—including diet advice, physical activity, stress management, and social support—can improve quality of life and long-term outcomes for women with stage II or III breast cancer undergoing radiation therapy. About 110 partici…
Matched conditions: STAGE II BREAST CANCER AJCC V6 AND V7
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 22, 2026 13:50 UTC
-
Shorter radiation may spare side effects for breast cancer patients
Symptom relief OngoingThis study tested whether a shorter course of higher-dose radiation (hypofractionated) works as well as standard longer radiation for early-stage breast cancer. About 300 women with ductal carcinoma in situ or early invasive breast cancer took part. The goal was to see if the sho…
Matched conditions: STAGE II BREAST CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 19, 2026 11:48 UTC
-
Acupuncture offers hope for breast cancer survivors in pain
Symptom relief OngoingThis study tests whether a type of acupuncture using mild electrical pulses can reduce chronic pain in women who have finished treatment for early-stage breast cancer. About 111 women with persistent pain for at least 3 months after surgery will receive either real acupuncture, a…
Matched conditions: STAGE II BREAST CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 18, 2026 12:03 UTC